Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study

NCT07706829 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT07706829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07706829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2027
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hyposmia, neurogenic orthostatic hypotension, parkinson disease (pd), rem sleep behavior disorder (irbd)